Rachel Vatnsdal

Stock Analyst at JP Morgan

(0.23)
# 2109
Out of 5,243 analysts
56
Total ratings
52.63%
Success rate
9.65%
Average return
19 Stocks
Name Action Price Target Current % Upside Ratings Updated
A
Agilent Technologies
Maintains: Overweight
165 160
142.18 12.53% 6 Nov 26, 2024
Waters
Maintains: Neutral
340 380
397.49 -4.4% 3 Nov 4, 2024
10x Genomics
Maintains: Neutral
20 14
14.98 -6.54% 2 Oct 30, 2024
Thermo Fisher Scient...
Maintains: Overweight
650 670
551.61 21.46% 8 Sep 20, 2024
Henry Schein
Maintains: Overweight
88 80
71.14 12.45% 3 Aug 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
23 16
19.22 -16.75% 3 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
42 47
34.88 34.75% 2 Aug 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
17 20
13.14 52.21% 3 Aug 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Aug 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
1300 1400
1279.28 9.44% 2 Aug 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
5 6
7.15 -16.08% 4 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
190 200
157.12 27.29% 4 Jul 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
105 120
118.88 0.94% 3 Jul 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Apr 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
60 90
57.65 56.11% 2 Feb 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
250 270
237.85 13.52% 4 Dec 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Nov 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
90 45
n/a n/a 1 May 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
n/a
n/a n/a 2 Nov 10, 2022